Indraprastha Medical Corporation Limited (NSE:INDRAMEDCO)

India flag India · Delayed Price · Currency is INR
450.35
-11.05 (-2.39%)
Aug 8, 2025, 3:30 PM IST
-2.39%
Market Cap41.28B
Revenue (ttm)13.74B
Net Income (ttm)1.68B
Shares Out91.67M
EPS (ttm)18.29
PE Ratio24.62
Forward PEn/a
Dividend4.50 (1.00%)
Ex-Dividend DateSep 18, 2025
Volume220,040
Average Volume221,589
Open465.05
Previous Close461.40
Day's Range448.75 - 471.00
52-Week Range307.25 - 572.00
Beta0.59
RSI44.67
Earnings DateJul 31, 2025

About NSE:INDRAMEDCO

Indraprastha Medical Corporation Limited provides hospital services in India. It offers services primarily in the areas of sugar, genomic medicine, elder care, anesthesiology, bariatric and metabolic surgery, bone marrow transplant, dental and cosmetic clinic, dermatology, dietetics and clinical nutrition, vascular and endovascular surgery, endocrinology, ENT, fetal medicine, general and laparoscopic surgery, gynecology and obstetrics, hyperbaric oxygen therapy, IVF, neonatology, nephrology, nuclear medicine, ophthalmology, pediatric sciences, ... [Read more]

Sector Healthcare
Founded 1983
Employees 2,977
Stock Exchange National Stock Exchange of India
Ticker Symbol INDRAMEDCO
Full Company Profile

Financial Performance

In 2024, NSE:INDRAMEDCO's revenue was 13.56 billion, an increase of 8.97% compared to the previous year's 12.45 billion. Earnings were 1.61 billion, an increase of 29.87%.

Financial Statements

News

There is no news available yet.